WHO Backs Pfizer's Oral COVID Therapy for High-Risk Patients
The World Health Organization (WHO) on Thursday endorsed the use of Pfizer Inc's oral COVID-19 antiviral treatment in high-risk patients after an analysis of trial data by the U.N. agency showed the therapy dramatically cut the risk of hospitalization. More treatment, more safety!
Photo Credit: Pawel Czerwinski